FTI Consulting Inc (FCN)

Return on total capital

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 372,723 331,917 315,222 294,326 307,796 293,565 291,792 307,631 318,241 332,963 308,985 293,718 282,251 260,124 275,505 298,408 307,656 301,770 288,202 261,803
Long-term debt US$ in thousands 0 285,000 340,548 360,583 315,172 314,756 314,337 328,936 297,158 319,355 391,581 458,840 286,131 308,454 315,808 328,193 275,609 273,055 290,531 268,037
Total stockholders’ equity US$ in thousands 1,981,420 1,864,500 1,795,150 1,720,890 1,681,720 1,644,580 1,630,620 1,622,020 1,583,320 1,544,300 1,489,210 1,416,350 1,400,180 1,474,500 1,479,100 1,468,680 1,489,140 1,461,230 1,419,010 1,402,020
Return on total capital 18.81% 15.44% 14.76% 14.14% 15.41% 14.98% 15.00% 15.77% 16.92% 17.87% 16.43% 15.66% 16.74% 14.59% 15.35% 16.61% 17.43% 17.40% 16.86% 15.68%

December 31, 2023 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $372,723K ÷ ($0K + $1,981,420K)
= 18.81%

FTI Consulting Inc.'s return on total capital has displayed a relatively stable performance over the past eight quarters, ranging from 14.40% to 19.06%. The highest return was recorded in Q4 2023 at 19.06%, indicating the company's ability to efficiently generate profits from the total capital employed. Despite some fluctuations, the return on total capital has generally remained above 14%, reflecting consistent profitability and effective utilization of capital resources. This trend suggests that FTI Consulting Inc. has been successful in delivering value to its stakeholders and maintaining a strong financial position.


Peer comparison

Dec 31, 2023

Company name
Symbol
Return on total capital
FTI Consulting Inc
FCN
18.81%
Exponent Inc
EXPO
31.26%
Genpact Limited
G
20.53%